Endoscopic Vessel Harvesting System Market Trends & Future Outlook, 2033 | UnivDatos

The Endoscopic Vessel Harvesting System Market is set to show a growth rate of about 4.2% during the forecast period (2025-2033F). The Endoscopic Vessel Harvesting System market is on the rise because of the increase in cardiovascular diseases and the number of coronary artery bypass graft surgeries in the world. Minimally invasive procedures are becoming increasingly popular within the surgery and hospital sector to minimize patient complications, postoperative pain, and infection. EVH systems have reduced recovery times, provide better cosmetic results, and reduce total healthcare expenses, which are appealing to healthcare providers. Technological advancements, such as improved visualization, ergonomic design, and enhanced vessel integrity, further encourage adoption. Also, increasing awareness of clinicians and patients, and the increasing care infrastructure in emerging economies, are increasing the pace of growth in the market.

An Endoscopic Vessel Harvesting (EVH) System is a surgical system of minimal invasiveness that is employed to harvest blood vessels (generally the saphenous vein or radial artery) to be utilized in coronary artery bypass graft (CABG) and other vascular surgeries. This system is done using the small incision, endoscope, and special instruments in order to dissect and remove the vessel, leaving the surrounding tissue intact. EVH systems cause less trauma in surgery, postoperative pain, scarring, and infection compared to other open harvesting methods. They also help in the accelerated healing of the patients, reduce inpatient care, and enhance cosmetic results without compromising on the quality of the grafts and efficiency of the procedure.

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/endoscopic-vessel-harvesting-system-market

List of Top Companies Operating in Endoscopic Vessel Harvesting Systems Worldwide:

The global endoscopic vessel harvesting system market has several major players, including Terumo Corporation, Medtronic Plc, B. Braun Melsungen AG, Boston Scientific Corporation, and Getinge. More information about these companies has been provided below:

1.    Terumo Corporation

Terumo Corporation manufactures and sells medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: cardiac and vascular company, medical care solutions company, and blood and cell technologies company. The cardiac and vascular company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, endoscopes, endoscopic vessel harvesting systems, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and other medical tools and equipment.

2.    Medtronic Plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The cardiovascular portfolio segment comprises implantable cardiac pacemakers, cardioverter-defibrillators, cardiac resynchronization therapy devices, cardiac ablation products, endoscopic vessel harvesting systems, and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, transcatheter pulmonary valves, percutaneous coronary intervention products, percutaneous angioplasty balloons, and other medical products.

3.    B. Braun Melsungen AG

B. Braun Melsungen AG is a major global medical technology and pharmaceutical company headquartered in Germany. The company offers a broad portfolio of healthcare products and systems, including surgical instruments, infusion therapy solutions, wound care, vascular access devices, endoscopes, EVH systems, and equipment for anesthesia, cardiology, and extracorporeal blood treatment. B. Braun serves hospitals, clinics, physician practices, and home care sectors with over 5,000 products, of which the vast majority are manufactured in-house. The company emphasizes innovation, sustainability, and clinical value, investing significantly in R&D and advanced manufacturing to improve patient outcomes and support healthcare infrastructure worldwide.

4.    Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The company manufactures a wide range of medical devices and equipment, including stents, EVH systems, guidewires, and imaging systems, among others.

5.    Getinge

Getinge is a global medical technology company headquartered in Sweden, specializing in products and solutions for intensive care, cardiovascular procedures, operating rooms, and sterile processing. The company has a strong presence in the cardiovascular surgery segment, offering advanced technologies that support minimally invasive procedures, including endoscopic vessel harvesting systems. Getinge focuses on improving clinical outcomes, enhancing patient safety, and increasing operational efficiency for healthcare providers. With operations in over 40 countries and a broad global distribution network, the company serves hospitals and healthcare facilities worldwide.

Related Reports:-

Endoscopy Procedures Estimates Market: Current Analysis and Forecast (2022-2030)

Endoscopic Clips Market: Current Analysis and Forecast (2022-2028)

Sinus Dilation Device Market: Current Analysis and Forecast (2022-2028)

Medical Equipment Maintenance Market: Current Analysis and Forecast (2021-2027)

Southeast Asia Pacemakers Market: Current Analysis and Forecast (2025-2033)

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/